Haemophilus influenzae type b conjugate vaccine (Lanzhou Institute of Biological Products)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameHaemophilus influenzae type b conjugate vaccine (Lanzhou Institute of Biological Products)
Drug Alias Name呵儿贝
ClassificationVaccines > Vaccine type > Univalent vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsHaemophilus Infections
Approved Indications in ChinaHaemophilus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2003/12/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07AG01
Related LinksN/A